Skip to main content
Erschienen in: Heart Failure Reviews 2/2021

29.07.2020 | Cardiomyopathy

Cardiac complications in inherited mitochondrial diseases

verfasst von: Mohaddeseh Behjati, Mohammad Reza Sabri, Masood Etemadi Far, Majid Nejati

Erschienen in: Heart Failure Reviews | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Maternally mitochondrial dysfunction includes a heterogeneous group of genetic disorders which leads to the impairment of the final common pathway of energy metabolism. Coronary heart disease and coronary venous disease are two important clinical manifestations of mitochondrial dysfunction due to abnormality in the setting of underlying pathways. Mitochondrial dysfunction can lead to cardiomyopathy, which is involved in the onset of acute cardiac and pulmonary failure. Mitochondrial diseases present other cardiac manifestations such as left ventricular noncompaction and cardiac conduction disease. Different clinical findings from mitochondrial dysfunction originate from different mtDNA mutations, and this variety of clinical symptoms poses a diagnostic challenge for cardiologists. Heart transplantation may be a good treatment, but it is not always possible, and other complications of the disease, such as mitochondrial encephalopathy, lactic acidosis, and stroke-like syndrome, should be considered. To diagnose and treat most mitochondrial disorders, careful cardiac, neurological, and molecular studies are needed. In this study, we looked at molecular genetics of MIDs and cardiac manifestations in patients with mitochondrial dysfunction.
Literatur
1.
Zurück zum Zitat Osellame LD, Blacker TS, Duchen MR (2012) Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab 26:711–723PubMedPubMedCentral Osellame LD, Blacker TS, Duchen MR (2012) Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab 26:711–723PubMedPubMedCentral
2.
Zurück zum Zitat Rizzuto R, De Stefani D, Raffaello A, Mammucari C (2012) Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol 13:566PubMed Rizzuto R, De Stefani D, Raffaello A, Mammucari C (2012) Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol 13:566PubMed
3.
Zurück zum Zitat Jacobs L, de Wert G, Geraedts J, De Coo I, Smeets H (2005) The transmission of OXPHOS disease and methods to prevent this. Hum Reprod Update 12:119–136PubMed Jacobs L, de Wert G, Geraedts J, De Coo I, Smeets H (2005) The transmission of OXPHOS disease and methods to prevent this. Hum Reprod Update 12:119–136PubMed
4.
Zurück zum Zitat Nejati M, Atlasi MA, Karimian M, Nikzad H, Tameh AA (2018) Lipoprotein lipase gene polymorphisms as risk factors for stroke: a computational and meta-analysis. Iran J Basic Med Sci 21:701PubMedPubMedCentral Nejati M, Atlasi MA, Karimian M, Nikzad H, Tameh AA (2018) Lipoprotein lipase gene polymorphisms as risk factors for stroke: a computational and meta-analysis. Iran J Basic Med Sci 21:701PubMedPubMedCentral
5.
Zurück zum Zitat DiMauro S, Hirano M (2011) Mitochondrial encephalomyopathies: an update. Neuromuscul Disord 15:276–286 DiMauro S, Hirano M (2011) Mitochondrial encephalomyopathies: an update. Neuromuscul Disord 15:276–286
6.
Zurück zum Zitat Pohjoismäki JL, Goffart S, Taylor RW, Turnbull DM, Suomalainen A, Jacobs HT et al (2010) Developmental and pathological changes in the human cardiac muscle mitochondrial DNA organization, replication and copy number. PLoS One 5:e10426PubMedPubMedCentral Pohjoismäki JL, Goffart S, Taylor RW, Turnbull DM, Suomalainen A, Jacobs HT et al (2010) Developmental and pathological changes in the human cardiac muscle mitochondrial DNA organization, replication and copy number. PLoS One 5:e10426PubMedPubMedCentral
7.
Zurück zum Zitat Shoubridge EA, Wai T (2007) Mitochondrial DNA and the mammalian oocyte. Curr Top Dev Biol 77:87–111PubMed Shoubridge EA, Wai T (2007) Mitochondrial DNA and the mammalian oocyte. Curr Top Dev Biol 77:87–111PubMed
8.
Zurück zum Zitat Johns DR (1995) Mitochondrial DNA and disease. N Engl J Med 333:638–644PubMed Johns DR (1995) Mitochondrial DNA and disease. N Engl J Med 333:638–644PubMed
9.
Zurück zum Zitat Wallace DC, Chalkia D (2013) Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol 5:a021220PubMedPubMedCentral Wallace DC, Chalkia D (2013) Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol 5:a021220PubMedPubMedCentral
10.
Zurück zum Zitat Bates MG, Bourke JP, Giordano C, d'Amati G, Turnbull DM, Taylor RW (2012) Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management. Eur Heart J 33:3023–3033PubMedPubMedCentral Bates MG, Bourke JP, Giordano C, d'Amati G, Turnbull DM, Taylor RW (2012) Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management. Eur Heart J 33:3023–3033PubMedPubMedCentral
11.
Zurück zum Zitat Niyazov DM, Kahler SG, Frye RE (2016) Primary mitochondrial disease and secondary mitochondrial dysfunction: importance of distinction for diagnosis and treatment. Mol Syndromol 7:122–137PubMedPubMedCentral Niyazov DM, Kahler SG, Frye RE (2016) Primary mitochondrial disease and secondary mitochondrial dysfunction: importance of distinction for diagnosis and treatment. Mol Syndromol 7:122–137PubMedPubMedCentral
12.
Zurück zum Zitat Chinnery P, Johnson M, Wardell T, Singh-Kler R, Hayes C, Brown D et al (2000) The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 48:188–193PubMed Chinnery P, Johnson M, Wardell T, Singh-Kler R, Hayes C, Brown D et al (2000) The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 48:188–193PubMed
13.
Zurück zum Zitat Pankuweit S, Richter A (2015) Mitochondrial disorders with cardiac dysfunction: an under-reported aetiology with phenotypic heterogeneity. Eur Heart J 36:2894–2897PubMed Pankuweit S, Richter A (2015) Mitochondrial disorders with cardiac dysfunction: an under-reported aetiology with phenotypic heterogeneity. Eur Heart J 36:2894–2897PubMed
14.
Zurück zum Zitat Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254–260PubMedPubMedCentral Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254–260PubMedPubMedCentral
15.
Zurück zum Zitat Tuppen HA, Blakely EL, Turnbull DM, Taylor RW (2010) Mitochondrial DNA mutations and human disease. Biochim Biophys Acta Bioenerg 1797:113–128 Tuppen HA, Blakely EL, Turnbull DM, Taylor RW (2010) Mitochondrial DNA mutations and human disease. Biochim Biophys Acta Bioenerg 1797:113–128
16.
Zurück zum Zitat Luft JH (1961) Improvements in epoxy resin embedding methods. J Cell Biol 9:409–414 Luft JH (1961) Improvements in epoxy resin embedding methods. J Cell Biol 9:409–414
17.
18.
Zurück zum Zitat Di Donato S (2009) Multisystem manifestations of mitochondrial disorders. J Neurol 256:693–710PubMed Di Donato S (2009) Multisystem manifestations of mitochondrial disorders. J Neurol 256:693–710PubMed
19.
Zurück zum Zitat Hamilton GC, Eilers MA, Pacholka R, Brooks T (1991) Objectives to direct the training of emergency medicine residents on off-service rotation: otolaryngology. J Emerg Med 9:75–80PubMed Hamilton GC, Eilers MA, Pacholka R, Brooks T (1991) Objectives to direct the training of emergency medicine residents on off-service rotation: otolaryngology. J Emerg Med 9:75–80PubMed
20.
Zurück zum Zitat Dai D-F, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS (2014) Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan 3:1–22 Dai D-F, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS (2014) Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan 3:1–22
21.
Zurück zum Zitat Choi B-O, Hwang JH, Cho EM, Jeong EH, Hyun YS, Jeon HJ, Seong KM, Cho NS, Chung KW (2010) Mutational analysis of whole mitochondrial DNA in patients with MELAS and MERRF diseases. Exp Mol Med 42:446–455PubMedPubMedCentral Choi B-O, Hwang JH, Cho EM, Jeong EH, Hyun YS, Jeon HJ, Seong KM, Cho NS, Chung KW (2010) Mutational analysis of whole mitochondrial DNA in patients with MELAS and MERRF diseases. Exp Mol Med 42:446–455PubMedPubMedCentral
22.
Zurück zum Zitat Taylor RW, Giordano C, Davidson MM, d’Amati G, Bain H, Hayes CM, Leonard H, Barron MJ, Casali C, Santorelli FM, Hirano M, Lightowlers RN, DiMauro S, Turnbull DM (2003) A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J Am Coll Cardiol 41:1786–1796PubMed Taylor RW, Giordano C, Davidson MM, d’Amati G, Bain H, Hayes CM, Leonard H, Barron MJ, Casali C, Santorelli FM, Hirano M, Lightowlers RN, DiMauro S, Turnbull DM (2003) A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J Am Coll Cardiol 41:1786–1796PubMed
23.
Zurück zum Zitat Perli E, Giordano C, Tuppen HA, Montopoli M, Montanari A, Orlandi M et al (2011) Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m. 4277T> C mitochondrial tRNAIle mutation causing hypertrophic cardiomyopathy. Hum Mol Genet 21:85–100PubMed Perli E, Giordano C, Tuppen HA, Montopoli M, Montanari A, Orlandi M et al (2011) Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m. 4277T> C mitochondrial tRNAIle mutation causing hypertrophic cardiomyopathy. Hum Mol Genet 21:85–100PubMed
24.
Zurück zum Zitat Krishnan KJ, Reeve AK, Samuels DC, Chinnery PF, Blackwood JK, Taylor RW et al (2008) What causes mitochondrial DNA deletions in human cells? Nat Genet 40:275PubMed Krishnan KJ, Reeve AK, Samuels DC, Chinnery PF, Blackwood JK, Taylor RW et al (2008) What causes mitochondrial DNA deletions in human cells? Nat Genet 40:275PubMed
25.
Zurück zum Zitat Carling PJ, Cree LM, Chinnery PF (2011) The implications of mitochondrial DNA copy number regulation during embryogenesis. Mitochondrion. 11:686–692PubMed Carling PJ, Cree LM, Chinnery PF (2011) The implications of mitochondrial DNA copy number regulation during embryogenesis. Mitochondrion. 11:686–692PubMed
26.
Zurück zum Zitat Shock LS, Thakkar PV, Peterson EJ, Moran RG, Taylor SM (2011) DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc Natl Acad Sci 108:3630–3635PubMed Shock LS, Thakkar PV, Peterson EJ, Moran RG, Taylor SM (2011) DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria. Proc Natl Acad Sci 108:3630–3635PubMed
27.
Zurück zum Zitat Byun H-M, Panni T, Motta V, Hou L, Nordio F, Apostoli P, Bertazzi P, Baccarelli AA (2013) Effects of airborne pollutants on mitochondrial DNA methylation. Part Fibre Toxicol 10:18PubMedPubMedCentral Byun H-M, Panni T, Motta V, Hou L, Nordio F, Apostoli P, Bertazzi P, Baccarelli AA (2013) Effects of airborne pollutants on mitochondrial DNA methylation. Part Fibre Toxicol 10:18PubMedPubMedCentral
28.
Zurück zum Zitat Liu B, Du Q, Chen L, Fu G, Li S, Fu L et al (2016) CpG methylation patterns of human mitochondrial DNA. Sci Rep 6:1–10 Liu B, Du Q, Chen L, Fu G, Li S, Fu L et al (2016) CpG methylation patterns of human mitochondrial DNA. Sci Rep 6:1–10
29.
Zurück zum Zitat Baccarelli AA, Byun H-M (2015) Platelet mitochondrial DNA methylation: a potential new marker of cardiovascular disease. Clin Epigenetics 7:44PubMedPubMedCentral Baccarelli AA, Byun H-M (2015) Platelet mitochondrial DNA methylation: a potential new marker of cardiovascular disease. Clin Epigenetics 7:44PubMedPubMedCentral
30.
Zurück zum Zitat Iacobazzi V, Castegna A, Infantino V, Andria G (2013) Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol Genet Metab 110:25–34PubMed Iacobazzi V, Castegna A, Infantino V, Andria G (2013) Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol Genet Metab 110:25–34PubMed
31.
Zurück zum Zitat Saeedi Borujeni MJ, Esfandiary E, Baradaran A, Valiani A, Ghanadian M, Codoñer-Franch P, Basirat R, Alonso-Iglesias E, Mirzaei H, Yazdani A (2019) Molecular aspects of pancreatic β-cell dysfunction: oxidative stress, microRNA, and long noncoding RNA. J Cell Physiol 234:8411–8425PubMed Saeedi Borujeni MJ, Esfandiary E, Baradaran A, Valiani A, Ghanadian M, Codoñer-Franch P, Basirat R, Alonso-Iglesias E, Mirzaei H, Yazdani A (2019) Molecular aspects of pancreatic β-cell dysfunction: oxidative stress, microRNA, and long noncoding RNA. J Cell Physiol 234:8411–8425PubMed
32.
Zurück zum Zitat Hashemian SM, Pourhanifeh MH, Fadaei S, Velayati AA, Mirzaei H, Hamblin MR (2020) Non-coding RNAs and exosomes: their role in the pathogenesis of sepsis. Mol Ther Nucleic Acids 21:51–74PubMedPubMedCentral Hashemian SM, Pourhanifeh MH, Fadaei S, Velayati AA, Mirzaei H, Hamblin MR (2020) Non-coding RNAs and exosomes: their role in the pathogenesis of sepsis. Mol Ther Nucleic Acids 21:51–74PubMedPubMedCentral
33.
Zurück zum Zitat Yousefi F, Shabaninejad Z, Vakili S, Derakhshan M, Movahedpour A, Dabiri H et al (2020) TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus. Cell Commun Signal 18:87PubMedPubMedCentral Yousefi F, Shabaninejad Z, Vakili S, Derakhshan M, Movahedpour A, Dabiri H et al (2020) TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus. Cell Commun Signal 18:87PubMedPubMedCentral
34.
Zurück zum Zitat Naeli P, Pourhanifeh MH, Karimzadeh MR, Shabaninejad Z, Movahedpour A, Tarrahimofrad H, Mirzaei HR, Bafrani HH, Savardashtaki A, Mirzaei H, Hamblin MR (2020) Circular RNAs and gastrointestinal cancers: epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol 145:102854PubMed Naeli P, Pourhanifeh MH, Karimzadeh MR, Shabaninejad Z, Movahedpour A, Tarrahimofrad H, Mirzaei HR, Bafrani HH, Savardashtaki A, Mirzaei H, Hamblin MR (2020) Circular RNAs and gastrointestinal cancers: epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol 145:102854PubMed
35.
Zurück zum Zitat Shabaninejad Z, Vafadar A, Movahedpour A, Ghasemi Y, Namdar A, Fathizadeh H et al (2019) Circular RNAs in cancer: new insights into functions and implications in ovarian cancer. J Ovarian Res 12:84PubMedPubMedCentral Shabaninejad Z, Vafadar A, Movahedpour A, Ghasemi Y, Namdar A, Fathizadeh H et al (2019) Circular RNAs in cancer: new insights into functions and implications in ovarian cancer. J Ovarian Res 12:84PubMedPubMedCentral
36.
Zurück zum Zitat Vafadar A, Shabaninejad Z, Movahedpour A, Mohammadi S, Fathullahzadeh S, Mirzaei HR, Namdar A, Savardashtaki A, Mirzaei H (2019) Long non-coding RNAs as epigenetic regulators in Cancer. Curr Pharm Des 25:3563–3577PubMed Vafadar A, Shabaninejad Z, Movahedpour A, Mohammadi S, Fathullahzadeh S, Mirzaei HR, Namdar A, Savardashtaki A, Mirzaei H (2019) Long non-coding RNAs as epigenetic regulators in Cancer. Curr Pharm Des 25:3563–3577PubMed
37.
Zurück zum Zitat Mirzaei H, Yazdi F, Salehi R, Mirzaei HR (2016) SiRNA and epigenetic aberrations in ovarian cancer. J Cancer Res Ther 12:498–508PubMed Mirzaei H, Yazdi F, Salehi R, Mirzaei HR (2016) SiRNA and epigenetic aberrations in ovarian cancer. J Cancer Res Ther 12:498–508PubMed
38.
Zurück zum Zitat Khani P, Nasri F, Khani Chamani F, Saeidi F, Sadri Nahand J, Tabibkhooei A et al (2019) Genetic and epigenetic contribution to astrocytic gliomas pathogenesis. J Neurochem 148:188–203PubMed Khani P, Nasri F, Khani Chamani F, Saeidi F, Sadri Nahand J, Tabibkhooei A et al (2019) Genetic and epigenetic contribution to astrocytic gliomas pathogenesis. J Neurochem 148:188–203PubMed
39.
Zurück zum Zitat Mirzaei H (2017) Stroke in women: risk factors and clinical biomarkers. J Cell Biochem 118:4191–4202PubMed Mirzaei H (2017) Stroke in women: risk factors and clinical biomarkers. J Cell Biochem 118:4191–4202PubMed
40.
Zurück zum Zitat Pourhanifeh MH, Mahjoubin-Tehran M, Karimzadeh MR, Mirzaei HR, Razavi ZS, Sahebkar A, Hosseini N, Mirzaei H, Hamblin MR (2020) Autophagy in cancers including brain tumors: role of MicroRNAs. Cell Commun Signal 18:88PubMedPubMedCentral Pourhanifeh MH, Mahjoubin-Tehran M, Karimzadeh MR, Mirzaei HR, Razavi ZS, Sahebkar A, Hosseini N, Mirzaei H, Hamblin MR (2020) Autophagy in cancers including brain tumors: role of MicroRNAs. Cell Commun Signal 18:88PubMedPubMedCentral
41.
Zurück zum Zitat Nahand JS, Taghizadeh-Boroujeni S, Karimzadeh M, Borran S, Pourhanifeh MH, Moghoofei M et al (2019) microRNAs: new prognostic, diagnostic, and therapeutic biomarkers in cervical cancer. J Cell Physiol 234:17064–17099PubMed Nahand JS, Taghizadeh-Boroujeni S, Karimzadeh M, Borran S, Pourhanifeh MH, Moghoofei M et al (2019) microRNAs: new prognostic, diagnostic, and therapeutic biomarkers in cervical cancer. J Cell Physiol 234:17064–17099PubMed
42.
Zurück zum Zitat Salarinia R, Sahebkar A, Peyvandi M, Mirzaei HR, Jaafari MR, Riahi MM et al (2016) Epi-drugs and Epi-miRs: moving beyond current cancer therapies. Curr Cancer Drug Targets 16:773–788PubMed Salarinia R, Sahebkar A, Peyvandi M, Mirzaei HR, Jaafari MR, Riahi MM et al (2016) Epi-drugs and Epi-miRs: moving beyond current cancer therapies. Curr Cancer Drug Targets 16:773–788PubMed
43.
Zurück zum Zitat Sadri Nahand J, Moghoofei M, Salmaninejad A, Bahmanpour Z, Karimzadeh M, Nasiri M, Mirzaei HR, Pourhanifeh MH, Bokharaei-Salim F, Mirzaei H, Hamblin MR (2020) Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: a review. Int J Cancer 146:305–320PubMed Sadri Nahand J, Moghoofei M, Salmaninejad A, Bahmanpour Z, Karimzadeh M, Nasiri M, Mirzaei HR, Pourhanifeh MH, Bokharaei-Salim F, Mirzaei H, Hamblin MR (2020) Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: a review. Int J Cancer 146:305–320PubMed
44.
Zurück zum Zitat Aghdam AM, Amiri A, Salarinia R, Masoudifar A, Ghasemi F, Mirzaei H (2019) MicroRNAs as diagnostic, prognostic, and therapeutic biomarkers in prostate Cancer. Crit Rev Eukaryot Gene Expr 29:127–139PubMed Aghdam AM, Amiri A, Salarinia R, Masoudifar A, Ghasemi F, Mirzaei H (2019) MicroRNAs as diagnostic, prognostic, and therapeutic biomarkers in prostate Cancer. Crit Rev Eukaryot Gene Expr 29:127–139PubMed
45.
Zurück zum Zitat Mirzaei H, Ferns GA, Avan A, Mobarhan MG (2017) Cytokines and MicroRNA in coronary artery disease. Adv Clin Chem 82:47–70PubMed Mirzaei H, Ferns GA, Avan A, Mobarhan MG (2017) Cytokines and MicroRNA in coronary artery disease. Adv Clin Chem 82:47–70PubMed
46.
Zurück zum Zitat Geiger J, Dalgaard LT (2017) Interplay of mitochondrial metabolism and microRNAs. Cell Mol Life Sci 74:631–646PubMed Geiger J, Dalgaard LT (2017) Interplay of mitochondrial metabolism and microRNAs. Cell Mol Life Sci 74:631–646PubMed
47.
Zurück zum Zitat Barrey E, Saint-Auret G, Bonnamy B, Damas D, Boyer O, Gidrol X (2011) Pre-microRNA and mature microRNA in human mitochondria. PLoS One 6:e20220PubMedPubMedCentral Barrey E, Saint-Auret G, Bonnamy B, Damas D, Boyer O, Gidrol X (2011) Pre-microRNA and mature microRNA in human mitochondria. PLoS One 6:e20220PubMedPubMedCentral
48.
Zurück zum Zitat Bienertova-Vasku J, Sana J, Slaby O (2013) The role of microRNAs in mitochondria in cancer. Cancer Lett 336:1–7PubMed Bienertova-Vasku J, Sana J, Slaby O (2013) The role of microRNAs in mitochondria in cancer. Cancer Lett 336:1–7PubMed
49.
Zurück zum Zitat Das S, Ferlito M, Kent OA, Fox-Talbot K, Wang R, Liu D, Raghavachari N, Yang Y, Wheelan SJ, Murphy E, Steenbergen C (2012) Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res 110:1596–1603PubMedPubMedCentral Das S, Ferlito M, Kent OA, Fox-Talbot K, Wang R, Liu D, Raghavachari N, Yang Y, Wheelan SJ, Murphy E, Steenbergen C (2012) Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res 110:1596–1603PubMedPubMedCentral
50.
Zurück zum Zitat Chen Y, Liu Y, Dorn GW (2011) Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ Res 109:1327–1331PubMedPubMedCentral Chen Y, Liu Y, Dorn GW (2011) Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ Res 109:1327–1331PubMedPubMedCentral
51.
Zurück zum Zitat Villar P, Bretón B, García-Pavía P, González-Páramos C, Blázquez A, Gómez-Bueno M et al (2013) Cardiac dysfunction in mitochondrial disease. Circ J 77:279–286 Villar P, Bretón B, García-Pavía P, González-Páramos C, Blázquez A, Gómez-Bueno M et al (2013) Cardiac dysfunction in mitochondrial disease. Circ J 77:279–286
52.
Zurück zum Zitat Limongelli G, Masarone D, D’Alessandro R, Elliott PM (2012) Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course. Futur Cardiol 8:71–88 Limongelli G, Masarone D, D’Alessandro R, Elliott PM (2012) Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course. Futur Cardiol 8:71–88
53.
Zurück zum Zitat Park S-Y, Gifford JR, Andtbacka RH, Trinity JD, Hyngstrom JR, Garten RS et al (2014) Cardiac, skeletal, and smooth muscle mitochondrial respiration: are all mitochondria created equal? Am J Phys Heart Circ Phys 307:H346–HH52 Park S-Y, Gifford JR, Andtbacka RH, Trinity JD, Hyngstrom JR, Garten RS et al (2014) Cardiac, skeletal, and smooth muscle mitochondrial respiration: are all mitochondria created equal? Am J Phys Heart Circ Phys 307:H346–HH52
54.
Zurück zum Zitat Meyers DE, Basha HI, Koenig MK (2013) Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management. Tex Heart Inst J 40:385PubMedPubMedCentral Meyers DE, Basha HI, Koenig MK (2013) Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management. Tex Heart Inst J 40:385PubMedPubMedCentral
55.
Zurück zum Zitat Jonckheere AI, Hogeveen M, Nijtmans L, Van Den Brand M, Janssen A, Diepstra J et al (2008) A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy. J Med Genet 45:129–133PubMed Jonckheere AI, Hogeveen M, Nijtmans L, Van Den Brand M, Janssen A, Diepstra J et al (2008) A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy. J Med Genet 45:129–133PubMed
56.
Zurück zum Zitat He R, Ding C, Yin P, He L, Xu Q, Wu Z, Shi Y, Su L (2019) MiR-1a-3p mitigates isoproterenol-induced heart failure by enhancing the expression of mitochondrial ND1 and COX1. Exp Cell Res 378:87–97PubMed He R, Ding C, Yin P, He L, Xu Q, Wu Z, Shi Y, Su L (2019) MiR-1a-3p mitigates isoproterenol-induced heart failure by enhancing the expression of mitochondrial ND1 and COX1. Exp Cell Res 378:87–97PubMed
57.
Zurück zum Zitat Mkaouar-Rebai E, Chamkha I, Mezghani N, Ayed IB, Fakhfakh F (2013) Screening of mitochondrial mutations in Tunisian patients with mitochondrial disorders: an overview study. Mitochondrial DNA 24:163–178PubMed Mkaouar-Rebai E, Chamkha I, Mezghani N, Ayed IB, Fakhfakh F (2013) Screening of mitochondrial mutations in Tunisian patients with mitochondrial disorders: an overview study. Mitochondrial DNA 24:163–178PubMed
58.
Zurück zum Zitat Liu Z, Song Y, Li D, He X, Li S, Wu B et al (2014) The novel mitochondrial 16S rRNA 2336T> C mutation is associated with hypertrophic cardiomyopathy. J Med Genet 51:176–184PubMed Liu Z, Song Y, Li D, He X, Li S, Wu B et al (2014) The novel mitochondrial 16S rRNA 2336T> C mutation is associated with hypertrophic cardiomyopathy. J Med Genet 51:176–184PubMed
59.
Zurück zum Zitat Palecek T, Tesarova M, Kuchynka P, Dytrych V, Elleder M, Hulkova H et al (2012) Hypertrophic cardiomyopathy due to the mitochondrial DNA mutation m. 3303C> T diagnosed in an adult male. Int Heart J 53:383–387PubMed Palecek T, Tesarova M, Kuchynka P, Dytrych V, Elleder M, Hulkova H et al (2012) Hypertrophic cardiomyopathy due to the mitochondrial DNA mutation m. 3303C> T diagnosed in an adult male. Int Heart J 53:383–387PubMed
60.
Zurück zum Zitat Zarrouk-Mahjoub S, Mehri S, Ouarda F, Finsterer J, Boussaada R (2015) Mitochondrial tRNA glutamine variant in hypertrophic cardiomyopathy. Herz. 40:436–441PubMed Zarrouk-Mahjoub S, Mehri S, Ouarda F, Finsterer J, Boussaada R (2015) Mitochondrial tRNA glutamine variant in hypertrophic cardiomyopathy. Herz. 40:436–441PubMed
61.
Zurück zum Zitat Bates MG, Nesbitt V, Kirk R, He L, Blakely EL, Alston CL et al (2012) Mitochondrial respiratory chain disease in children undergoing cardiac transplantation: a prospective study. Int J Cardiol 155:305–306PubMed Bates MG, Nesbitt V, Kirk R, He L, Blakely EL, Alston CL et al (2012) Mitochondrial respiratory chain disease in children undergoing cardiac transplantation: a prospective study. Int J Cardiol 155:305–306PubMed
62.
Zurück zum Zitat Götz A, Tyynismaa H, Euro L, Ellonen P, Hyötyläinen T, Ojala T, Hämäläinen RH, Tommiska J, Raivio T, Oresic M, Karikoski R, Tammela O, Simola KOJ, Paetau A, Tyni T, Suomalainen A (2011) Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet 88:635–642PubMedPubMedCentral Götz A, Tyynismaa H, Euro L, Ellonen P, Hyötyläinen T, Ojala T, Hämäläinen RH, Tommiska J, Raivio T, Oresic M, Karikoski R, Tammela O, Simola KOJ, Paetau A, Tyni T, Suomalainen A (2011) Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet 88:635–642PubMedPubMedCentral
63.
Zurück zum Zitat Echaniz-Laguna A, Chassagne M, Ceresuela J, Rouvet I, Padet S, Acquaviva C, Nataf S, Vinzio S, Bozon D, Mousson de Camaret B (2012) Complete loss of expression of the ANT1 gene causing cardiomyopathy and myopathy. J Med Genet 49:146–150PubMed Echaniz-Laguna A, Chassagne M, Ceresuela J, Rouvet I, Padet S, Acquaviva C, Nataf S, Vinzio S, Bozon D, Mousson de Camaret B (2012) Complete loss of expression of the ANT1 gene causing cardiomyopathy and myopathy. J Med Genet 49:146–150PubMed
64.
Zurück zum Zitat Ware SM, El-Hassan N, Kahler S, Zhang Q, Miller E, Wong B et al (2009) Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes. J Med Genet 46:308–314PubMed Ware SM, El-Hassan N, Kahler S, Zhang Q, Miller E, Wong B et al (2009) Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes. J Med Genet 46:308–314PubMed
65.
Zurück zum Zitat Hejzlarova K, Mráček T, Vrbacký M, Kaplanova V, Karbanova V, Nůsková H et al (2014) Nuclear genetic defects of mitochondrial ATP synthase. Physiol Res 63:sS57–S71 Hejzlarova K, Mráček T, Vrbacký M, Kaplanova V, Karbanova V, Nůsková H et al (2014) Nuclear genetic defects of mitochondrial ATP synthase. Physiol Res 63:sS57–S71
66.
Zurück zum Zitat Rahman OU, Khawar N, Khan MA, Ahmed J, Khattak K, Al-Aama JY et al (2013) Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family. Diagn Pathol 8:78PubMedPubMedCentral Rahman OU, Khawar N, Khan MA, Ahmed J, Khattak K, Al-Aama JY et al (2013) Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family. Diagn Pathol 8:78PubMedPubMedCentral
67.
Zurück zum Zitat Krzywanski DM, Moellering DR, Fetterman JL, Dunham-Snary KJ, Sammy MJ, Ballinger SW (2011) The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics. Lab Investig 91:1122PubMed Krzywanski DM, Moellering DR, Fetterman JL, Dunham-Snary KJ, Sammy MJ, Ballinger SW (2011) The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics. Lab Investig 91:1122PubMed
68.
Zurück zum Zitat Van den Heuvel L, Smits P, Saada A, Wortmann S, Heister A, Miller C, et al. (2010) Mutation in mitochondrial ribosomal protein MRPS22 leads to Cornelia de Lange-like phenotype, brain abnormalities and hypertrophic cardiomyopathy. Eur J Hum Genet 19:394–399 Van den Heuvel L, Smits P, Saada A, Wortmann S, Heister A, Miller C, et al. (2010) Mutation in mitochondrial ribosomal protein MRPS22 leads to Cornelia de Lange-like phenotype, brain abnormalities and hypertrophic cardiomyopathy. Eur J Hum Genet 19:394–399
69.
Zurück zum Zitat Carroll CJ, Isohanni P, Pöyhönen R, Euro L, Richter U, Brilhante V, Götz A, Lahtinen T, Paetau A, Pihko H, Battersby BJ, Tyynismaa H, Suomalainen A (2013) Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to underlie mitochondrial infantile cardiomyopathy. J Med Genet 50:151–159PubMed Carroll CJ, Isohanni P, Pöyhönen R, Euro L, Richter U, Brilhante V, Götz A, Lahtinen T, Paetau A, Pihko H, Battersby BJ, Tyynismaa H, Suomalainen A (2013) Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to underlie mitochondrial infantile cardiomyopathy. J Med Genet 50:151–159PubMed
70.
Zurück zum Zitat Galmiche L, Serre V, Beinat M, Assouline Z, Lebre AS, Chretien D, Nietschke P, Benes V, Boddaert N, Sidi D, Brunelle F, Rio M, Munnich A, Rötig A (2011) Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy. Hum Mutat 32:1225–1231PubMed Galmiche L, Serre V, Beinat M, Assouline Z, Lebre AS, Chretien D, Nietschke P, Benes V, Boddaert N, Sidi D, Brunelle F, Rio M, Munnich A, Rötig A (2011) Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy. Hum Mutat 32:1225–1231PubMed
71.
Zurück zum Zitat Baruffini E, Dallabona C, Invernizzi F, Yarham JW, Melchionda L, Blakely EL, Lamantea E, Donnini C, Santra S, Vijayaraghavan S, Roper HP, Burlina A, Kopajtich R, Walther A, Strom TM, Haack TB, Prokisch H, Taylor RW, Ferrero I, Zeviani M, Ghezzi D (2013) MTO 1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast. Hum Mutat 34:1501–1509PubMedPubMedCentral Baruffini E, Dallabona C, Invernizzi F, Yarham JW, Melchionda L, Blakely EL, Lamantea E, Donnini C, Santra S, Vijayaraghavan S, Roper HP, Burlina A, Kopajtich R, Walther A, Strom TM, Haack TB, Prokisch H, Taylor RW, Ferrero I, Zeviani M, Ghezzi D (2013) MTO 1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast. Hum Mutat 34:1501–1509PubMedPubMedCentral
72.
Zurück zum Zitat Fassone E, Taanman J-W, Hargreaves IP, Sebire NJ, Cleary MA, Burch M et al (2011) Mutations in the mitochondrial complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic cardiomyopathy. J Med Genet 48:691–697PubMed Fassone E, Taanman J-W, Hargreaves IP, Sebire NJ, Cleary MA, Burch M et al (2011) Mutations in the mitochondrial complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic cardiomyopathy. J Med Genet 48:691–697PubMed
73.
Zurück zum Zitat Ngu LH, Nijtmans LG, Distelmaier F, Venselaar H, van Emst-de Vries SE, van den Brand MA et al (2012) A catalytic defect in mitochondrial respiratory chain complex I due to a mutation in NDUFS2 in a patient with Leigh syndrome. Biochim Biophys Acta Mol Basis Dis 1822:168–175 Ngu LH, Nijtmans LG, Distelmaier F, Venselaar H, van Emst-de Vries SE, van den Brand MA et al (2012) A catalytic defect in mitochondrial respiratory chain complex I due to a mutation in NDUFS2 in a patient with Leigh syndrome. Biochim Biophys Acta Mol Basis Dis 1822:168–175
74.
Zurück zum Zitat Liu H-Y, Liao P-C, Chuang K-T, Kao M-C (2011) Mitochondrial targeting of human NADH dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2) and its association with early-onset hypertrophic cardiomyopathy and encephalopathy. J Biomed Sci 18:29PubMedPubMedCentral Liu H-Y, Liao P-C, Chuang K-T, Kao M-C (2011) Mitochondrial targeting of human NADH dehydrogenase (ubiquinone) flavoprotein 2 (NDUFV2) and its association with early-onset hypertrophic cardiomyopathy and encephalopathy. J Biomed Sci 18:29PubMedPubMedCentral
75.
Zurück zum Zitat Navarro-Sastre A, Tort F, Stehling O, Uzarska MA, Arranz JA, del Toro M, Labayru MT, Landa J, Font A, Garcia-Villoria J, Merinero B, Ugarte M, Gutierrez-Solana LG, Campistol J, Garcia-Cazorla A, Vaquerizo J, Riudor E, Briones P, Elpeleg O, Ribes A, Lill R (2011) A fatal mitochondrial disease is associated with defective NFU1 function in the maturation of a subset of mitochondrial Fe-S proteins. Am J Hum Genet 89:656–667PubMedPubMedCentral Navarro-Sastre A, Tort F, Stehling O, Uzarska MA, Arranz JA, del Toro M, Labayru MT, Landa J, Font A, Garcia-Villoria J, Merinero B, Ugarte M, Gutierrez-Solana LG, Campistol J, Garcia-Cazorla A, Vaquerizo J, Riudor E, Briones P, Elpeleg O, Ribes A, Lill R (2011) A fatal mitochondrial disease is associated with defective NFU1 function in the maturation of a subset of mitochondrial Fe-S proteins. Am J Hum Genet 89:656–667PubMedPubMedCentral
76.
Zurück zum Zitat Fassone E, Rahman S (2012) Complex I deficiency: clinical features, biochemistry and molecular genetics. J Med Genet 49:578–590PubMed Fassone E, Rahman S (2012) Complex I deficiency: clinical features, biochemistry and molecular genetics. J Med Genet 49:578–590PubMed
77.
Zurück zum Zitat Leary SC, Antonicka H, Sasarman F, Weraarpachai W, Cobine PA, Pan M et al (2013) Novel mutations in SCO 1 as a cause of fatal infantile encephalopathy and lactic acidosis. Hum Mutat 34:1366–1370PubMed Leary SC, Antonicka H, Sasarman F, Weraarpachai W, Cobine PA, Pan M et al (2013) Novel mutations in SCO 1 as a cause of fatal infantile encephalopathy and lactic acidosis. Hum Mutat 34:1366–1370PubMed
78.
Zurück zum Zitat Joost K, Rodenburg R, Piirsoo A, van den Heuvel B, Zordania R, Õunap K (2010) A novel mutation in the SCO2 gene in a neonate with early-onset cardioencephalomyopathy. Pediatr Neurol 42:227–230PubMed Joost K, Rodenburg R, Piirsoo A, van den Heuvel B, Zordania R, Õunap K (2010) A novel mutation in the SCO2 gene in a neonate with early-onset cardioencephalomyopathy. Pediatr Neurol 42:227–230PubMed
79.
Zurück zum Zitat Atay Z, Bereket A, Turan S, Haliloglu B, Memisoglu A, Khayat M, Shalev SA, Spiegel R (2013) A novel homozygous TMEM70 mutation results in congenital cataract and neonatal mitochondrial encephalo-cardiomyopathy. Gene. 515:197–199PubMed Atay Z, Bereket A, Turan S, Haliloglu B, Memisoglu A, Khayat M, Shalev SA, Spiegel R (2013) A novel homozygous TMEM70 mutation results in congenital cataract and neonatal mitochondrial encephalo-cardiomyopathy. Gene. 515:197–199PubMed
80.
Zurück zum Zitat Shahni R, Wedatilake Y, Cleary MA, Lindley KJ, Sibson KR, Rahman S (2013) A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations. Am J Med Genet A 161:2334–2338PubMedCentral Shahni R, Wedatilake Y, Cleary MA, Lindley KJ, Sibson KR, Rahman S (2013) A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations. Am J Med Genet A 161:2334–2338PubMedCentral
81.
Zurück zum Zitat Kabunga P, Lau AK, Phan K, Puranik R, Liang C, Davis RL, Sue CM, Sy RW (2015) Systematic review of cardiac electrical disease in Kearns–Sayre syndrome and mitochondrial cytopathy. Int J Cardiol 181:303–310PubMed Kabunga P, Lau AK, Phan K, Puranik R, Liang C, Davis RL, Sue CM, Sy RW (2015) Systematic review of cardiac electrical disease in Kearns–Sayre syndrome and mitochondrial cytopathy. Int J Cardiol 181:303–310PubMed
82.
Zurück zum Zitat Ayalon N, Flore LA, Christensen TG, Sam F (2013) Mitochondrial encoded NADH dehydrogenase 5 (MT-ND5) gene point mutation presents as late onset cardiomyopathy. Int J Cardiol 167:e143–e1e5PubMed Ayalon N, Flore LA, Christensen TG, Sam F (2013) Mitochondrial encoded NADH dehydrogenase 5 (MT-ND5) gene point mutation presents as late onset cardiomyopathy. Int J Cardiol 167:e143–e1e5PubMed
83.
Zurück zum Zitat Hollingsworth KG, Gorman GS, Trenell MI, McFarland R, Taylor RW, Turnbull DM, MacGowan GA, Blamire AM, Chinnery PF (2012) Cardiomyopathy is common in patients with the mitochondrial DNA m.3243A>G mutation and correlates with mutation load. Neuromuscul Disord 22:592–596PubMed Hollingsworth KG, Gorman GS, Trenell MI, McFarland R, Taylor RW, Turnbull DM, MacGowan GA, Blamire AM, Chinnery PF (2012) Cardiomyopathy is common in patients with the mitochondrial DNA m.3243A>G mutation and correlates with mutation load. Neuromuscul Disord 22:592–596PubMed
84.
Zurück zum Zitat Shikata C, Nemoto M, Ebisawa T, Nishiyama A, Takeda N (2011) Mitochondrial DNA and heart disease. Genes and Cardiovascular Function. Springer, Boston, p 79–84 Shikata C, Nemoto M, Ebisawa T, Nishiyama A, Takeda N (2011) Mitochondrial DNA and heart disease. Genes and Cardiovascular Function. Springer, Boston, p 79–84
85.
Zurück zum Zitat Peretto G, Durante A, Limite LR, Cianflone D (2014) Postoperative arrhythmias after cardiac surgery: incidence, risk factors, and therapeutic management.Cardiol Res Pract 2014:615987 Peretto G, Durante A, Limite LR, Cianflone D (2014) Postoperative arrhythmias after cardiac surgery: incidence, risk factors, and therapeutic management.Cardiol Res Pract 2014:615987
86.
Zurück zum Zitat Majamaa-Voltti K, Peuhkurinen K, Kortelainen M-L, Hassinen IE, Majamaa K (2002) Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovasc Disord 2:12PubMedPubMedCentral Majamaa-Voltti K, Peuhkurinen K, Kortelainen M-L, Hassinen IE, Majamaa K (2002) Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovasc Disord 2:12PubMedPubMedCentral
87.
Zurück zum Zitat Wilmin S, De Bels D, Knecht S, Gottignies P, Gazagnes M-D, Devriendt J (2012) Torsade de pointes in Kearns–Sayre syndrome. Pract Neurol 12:199–201PubMed Wilmin S, De Bels D, Knecht S, Gottignies P, Gazagnes M-D, Devriendt J (2012) Torsade de pointes in Kearns–Sayre syndrome. Pract Neurol 12:199–201PubMed
88.
Zurück zum Zitat Berardo A, Musumeci O, Toscano A (2011) Cardiological manifestations of mitochondrial respiratory chain disorders. Acta Myol 30:9PubMedPubMedCentral Berardo A, Musumeci O, Toscano A (2011) Cardiological manifestations of mitochondrial respiratory chain disorders. Acta Myol 30:9PubMedPubMedCentral
89.
Zurück zum Zitat Zhou N, Tang L, Jiang Y, Qin S, Cui J, Wang Y et al (2019) Whole-exome sequencing reveals a novel mutation of MT-ND5 gene in a mitochondrial cardiomyopathy pedigree: patients who show biventricular hypertrophy, hyperlactacidemia, pulmonary hypertension, and decreased exercise tolerance. Anatol J Cardiol 21:18PubMed Zhou N, Tang L, Jiang Y, Qin S, Cui J, Wang Y et al (2019) Whole-exome sequencing reveals a novel mutation of MT-ND5 gene in a mitochondrial cardiomyopathy pedigree: patients who show biventricular hypertrophy, hyperlactacidemia, pulmonary hypertension, and decreased exercise tolerance. Anatol J Cardiol 21:18PubMed
90.
Zurück zum Zitat Khullar M, Thangaraj K. Mitochondrial DNA variations associated with hypertrophic cardiomyopathy. 2013 Khullar M, Thangaraj K. Mitochondrial DNA variations associated with hypertrophic cardiomyopathy. 2013
91.
Zurück zum Zitat Vallance H, Jeven G, Wallace D, Brown M (2004) A case of sporadic infantile histiocytoid cardiomyopathy caused by the A8344G (MERRF) mitochondrial DNA mutation. Pediatr Cardiol 25:538–540PubMed Vallance H, Jeven G, Wallace D, Brown M (2004) A case of sporadic infantile histiocytoid cardiomyopathy caused by the A8344G (MERRF) mitochondrial DNA mutation. Pediatr Cardiol 25:538–540PubMed
92.
Zurück zum Zitat Finsterer J (2009) Manifestations of the mitochondrial A3243G mutation. Int J Cardiol 137:60–62PubMed Finsterer J (2009) Manifestations of the mitochondrial A3243G mutation. Int J Cardiol 137:60–62PubMed
93.
Zurück zum Zitat Wang S-B, Weng W-C, Lee N-C, Hwu W-L, Fan P-C, Lee W-T (2008) Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathy. Pediatr Neonatol 49:145–149PubMed Wang S-B, Weng W-C, Lee N-C, Hwu W-L, Fan P-C, Lee W-T (2008) Mutation of mitochondrial DNA G13513A presenting with Leigh syndrome, Wolff-Parkinson-White syndrome and cardiomyopathy. Pediatr Neonatol 49:145–149PubMed
94.
Zurück zum Zitat Riera ARP, Kaiser E, Levine P, Schapachnik E, Dubner S, Ferreira C et al (2008) Kearns-Sayre syndrome: electro-vectorcardiographic evolution for left septal fascicular block of the his bundle. J Electrocardiol 41:675–678PubMed Riera ARP, Kaiser E, Levine P, Schapachnik E, Dubner S, Ferreira C et al (2008) Kearns-Sayre syndrome: electro-vectorcardiographic evolution for left septal fascicular block of the his bundle. J Electrocardiol 41:675–678PubMed
95.
Zurück zum Zitat Verhoeven WM, Egger JI, Kremer BP, de Pont BJ, Marcelis CL (2011) Recurrent major depression, ataxia, and cardiomyopathy: association with a novel POLG mutation? Neuropsychiatr Dis Treat 7:293PubMedPubMedCentral Verhoeven WM, Egger JI, Kremer BP, de Pont BJ, Marcelis CL (2011) Recurrent major depression, ataxia, and cardiomyopathy: association with a novel POLG mutation? Neuropsychiatr Dis Treat 7:293PubMedPubMedCentral
96.
Zurück zum Zitat Planavila A, Dominguez E, Navarro M, Vinciguerra M, Iglesias R, Giralt M, Lope-Piedrafita S, Ruberte J, Villarroya F (2012) Dilated cardiomyopathy and mitochondrial dysfunction in Sirt1-deficient mice: a role for Sirt1-Mef2 in adult heart. J Mol Cell Cardiol 53:521–531PubMed Planavila A, Dominguez E, Navarro M, Vinciguerra M, Iglesias R, Giralt M, Lope-Piedrafita S, Ruberte J, Villarroya F (2012) Dilated cardiomyopathy and mitochondrial dysfunction in Sirt1-deficient mice: a role for Sirt1-Mef2 in adult heart. J Mol Cell Cardiol 53:521–531PubMed
97.
Zurück zum Zitat Vernengo L, Lilienbaum A, Agbulut O, Rodríguez M-M (2013) The role of genetics in cardiomyopathy. Cardiomyopathies, IntechOpen Vernengo L, Lilienbaum A, Agbulut O, Rodríguez M-M (2013) The role of genetics in cardiomyopathy. Cardiomyopathies, IntechOpen
98.
Zurück zum Zitat Wahbi K, Larue S, Jardel C, Meune C, Stojkovic T, Ziegler F, Lombes A, Eymard B, Duboc D, Laforet P (2010) Cardiac involvement is frequent in patients with the m.8344A>G mutation of mitochondrial DNA. Neurology. 74:674–677PubMed Wahbi K, Larue S, Jardel C, Meune C, Stojkovic T, Ziegler F, Lombes A, Eymard B, Duboc D, Laforet P (2010) Cardiac involvement is frequent in patients with the m.8344A>G mutation of mitochondrial DNA. Neurology. 74:674–677PubMed
99.
Zurück zum Zitat Jain-Ghai S, Cameron JM, Al Maawali A, Blaser S, MacKay N, Robinson B et al (2013) Complex II deficiency—a case report and review of the literature. Am J Med Genet A 161:285–294 Jain-Ghai S, Cameron JM, Al Maawali A, Blaser S, MacKay N, Robinson B et al (2013) Complex II deficiency—a case report and review of the literature. Am J Med Genet A 161:285–294
100.
Zurück zum Zitat Giordano C, Perli E, Orlandi M, Pisano A, Tuppen HA, He L, Ierinò R, Petruzziello L, Terzi A, Autore C, Petrozza V, Gallo P, Taylor RW, d'Amati G (2013) Cardiomyopathies due to homoplasmic mitochondrial tRNA mutations: morphologic and molecular features. Hum Pathol 44:1262–1270PubMed Giordano C, Perli E, Orlandi M, Pisano A, Tuppen HA, He L, Ierinò R, Petruzziello L, Terzi A, Autore C, Petrozza V, Gallo P, Taylor RW, d'Amati G (2013) Cardiomyopathies due to homoplasmic mitochondrial tRNA mutations: morphologic and molecular features. Hum Pathol 44:1262–1270PubMed
101.
Zurück zum Zitat Van Hove JL, Freehauf C, Miyamoto S, Vladutiu GD, Pancrudo J, Bonilla E et al (2008) Infantile cardiomyopathy caused by the T14709C mutation in the mitochondrial tRNA glutamic acid gene. Eur J Pediatr 167:771–776PubMed Van Hove JL, Freehauf C, Miyamoto S, Vladutiu GD, Pancrudo J, Bonilla E et al (2008) Infantile cardiomyopathy caused by the T14709C mutation in the mitochondrial tRNA glutamic acid gene. Eur J Pediatr 167:771–776PubMed
102.
Zurück zum Zitat Tang S, Batra A, Zhang Y, Ebenroth ES, Huang T (2010) Left ventricular noncompaction is associated with mutations in the mitochondrial genome. Mitochondrion. 10:350–357PubMed Tang S, Batra A, Zhang Y, Ebenroth ES, Huang T (2010) Left ventricular noncompaction is associated with mutations in the mitochondrial genome. Mitochondrion. 10:350–357PubMed
103.
Zurück zum Zitat Mahjoub SZ, Mehri S, Ourda F, Boussaada R, Mechmeche R, Arab SB et al (2011) Transition m. 3308T> C in the ND1 gene is associated with left ventricular hypertrabeculation/noncompaction. Cardiology. 118:153–158 Mahjoub SZ, Mehri S, Ourda F, Boussaada R, Mechmeche R, Arab SB et al (2011) Transition m. 3308T> C in the ND1 gene is associated with left ventricular hypertrabeculation/noncompaction. Cardiology. 118:153–158
104.
Zurück zum Zitat Liu S, Bai Y, Huang J, Zhao H, Zhang X, Hu S, Wei Y (2013) Do mitochondria contribute to left ventricular non-compaction cardiomyopathy? New findings from myocardium of patients with left ventricular non-compaction cardiomyopathy. Mol Genet Metab 109:100–106PubMed Liu S, Bai Y, Huang J, Zhao H, Zhang X, Hu S, Wei Y (2013) Do mitochondria contribute to left ventricular non-compaction cardiomyopathy? New findings from myocardium of patients with left ventricular non-compaction cardiomyopathy. Mol Genet Metab 109:100–106PubMed
105.
Zurück zum Zitat Finsterer J (2007) Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu (UUR) mutation. Acta Neurol Scand 116:1–14PubMed Finsterer J (2007) Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu (UUR) mutation. Acta Neurol Scand 116:1–14PubMed
106.
Zurück zum Zitat Malfatti E, Laforêt P, Jardel C, Stojkovic T, Behin A, Eymard B et al (2013) High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation. Neurology. 80:100–105PubMed Malfatti E, Laforêt P, Jardel C, Stojkovic T, Behin A, Eymard B et al (2013) High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation. Neurology. 80:100–105PubMed
107.
Zurück zum Zitat Karanikis P, Korantzopoulos P, Kountouris E, Dimitroula V, Patsouras D, Pappa E, Siogas K (2005) Kearns–Sayre syndrome associated with trifascicular block and QT prolongation. Int J Cardiol 101:147–150PubMed Karanikis P, Korantzopoulos P, Kountouris E, Dimitroula V, Patsouras D, Pappa E, Siogas K (2005) Kearns–Sayre syndrome associated with trifascicular block and QT prolongation. Int J Cardiol 101:147–150PubMed
108.
Zurück zum Zitat Ryan JJ, Marsboom G, Fang Y-H, Toth PT, Morrow E, Luo N, Piao L, Hong Z, Ericson K, Zhang HJ, Han M, Haney CR, Chen CT, Sharp WW, Archer SL (2013) PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension. Am J Respir Crit Care Med 187:865–878PubMedPubMedCentral Ryan JJ, Marsboom G, Fang Y-H, Toth PT, Morrow E, Luo N, Piao L, Hong Z, Ericson K, Zhang HJ, Han M, Haney CR, Chen CT, Sharp WW, Archer SL (2013) PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension. Am J Respir Crit Care Med 187:865–878PubMedPubMedCentral
109.
Zurück zum Zitat Hung P-C, Wang H-S, Chung H-T, Hwang M-S, Ro L-S (2012) Pulmonary hypertension in a child with mitochondrial A3243G point mutation. Brain and Development 34:866–868PubMed Hung P-C, Wang H-S, Chung H-T, Hwang M-S, Ro L-S (2012) Pulmonary hypertension in a child with mitochondrial A3243G point mutation. Brain and Development 34:866–868PubMed
110.
Zurück zum Zitat Indrieri A, Van Rahden VA, Tiranti V, Morleo M, Iaconis D, Tammaro R et al (2012) Mutations in COX7B cause microphthalmia with linear skin lesions, an unconventional mitochondrial disease. Am J Hum Genet 91:942–949PubMedPubMedCentral Indrieri A, Van Rahden VA, Tiranti V, Morleo M, Iaconis D, Tammaro R et al (2012) Mutations in COX7B cause microphthalmia with linear skin lesions, an unconventional mitochondrial disease. Am J Hum Genet 91:942–949PubMedPubMedCentral
111.
Zurück zum Zitat Belostotsky R, Ben-Shalom E, Rinat C, Becker-Cohen R, Feinstein S, Zeligson S, Segel R, Elpeleg O, Nassar S, Frishberg Y (2011) Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. Am J Hum Genet 88:193–200PubMedPubMedCentral Belostotsky R, Ben-Shalom E, Rinat C, Becker-Cohen R, Feinstein S, Zeligson S, Segel R, Elpeleg O, Nassar S, Frishberg Y (2011) Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. Am J Hum Genet 88:193–200PubMedPubMedCentral
112.
Zurück zum Zitat Fijołek J, Wiatr E, Wiechecka A, Torbicki A, Biederman A, Mickielewicz A et al (2003) Pulmonary thromboembolism as a late complication of mitochondrial myopathy (Kearns-Sayer syndrome). Pneumonol Alergol Pol 71:449–457PubMed Fijołek J, Wiatr E, Wiechecka A, Torbicki A, Biederman A, Mickielewicz A et al (2003) Pulmonary thromboembolism as a late complication of mitochondrial myopathy (Kearns-Sayer syndrome). Pneumonol Alergol Pol 71:449–457PubMed
113.
Zurück zum Zitat Prasad GN, Vanniarajan A, Emmanuel C, Cherian KM, Singh L, Thangaraj K (2006) Novel mitochondrial DNA mutations in a rare variety of hypertrophic cardiomyopathy. Int J Cardiol 109:432–433PubMed Prasad GN, Vanniarajan A, Emmanuel C, Cherian KM, Singh L, Thangaraj K (2006) Novel mitochondrial DNA mutations in a rare variety of hypertrophic cardiomyopathy. Int J Cardiol 109:432–433PubMed
114.
Zurück zum Zitat Cave D, Ross DB, Bahitham W, Chan A, Sergi C, Adatia I (2013) Mitochondrial DNA depletion syndrome-an unusual reason for interstage attrition after the modified stage 1 Norwood operation. Congenit Heart Dis 8:E20–E23PubMed Cave D, Ross DB, Bahitham W, Chan A, Sergi C, Adatia I (2013) Mitochondrial DNA depletion syndrome-an unusual reason for interstage attrition after the modified stage 1 Norwood operation. Congenit Heart Dis 8:E20–E23PubMed
115.
Zurück zum Zitat Majamaa-Voltti K, Majamaa K, Peuhkurinen K, Mäkikallio T, Huikuri H (2004) Cardiovascular autonomic regulation in patients with 3243A>G mitochondrial DNA mutation. Ann Med 36:225–231PubMed Majamaa-Voltti K, Majamaa K, Peuhkurinen K, Mäkikallio T, Huikuri H (2004) Cardiovascular autonomic regulation in patients with 3243A>G mitochondrial DNA mutation. Ann Med 36:225–231PubMed
116.
Zurück zum Zitat Brunetti-Pierri N, Pignatelli R, Fouladi N, Towbin JA, Belmont JW, Craigen WJ, Wong LJ, Jefferies JL, Scaglia F (2011) Dilation of the aortic root in mitochondrial disease patients. Mol Genet Metab 103:167–170PubMed Brunetti-Pierri N, Pignatelli R, Fouladi N, Towbin JA, Belmont JW, Craigen WJ, Wong LJ, Jefferies JL, Scaglia F (2011) Dilation of the aortic root in mitochondrial disease patients. Mol Genet Metab 103:167–170PubMed
117.
Zurück zum Zitat Ronchi D, Di Fonzo A, Lin W, Bordoni A, Liu C, Fassone E et al (2013) Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability. Am J Hum Genet 92:293–300PubMedPubMedCentral Ronchi D, Di Fonzo A, Lin W, Bordoni A, Liu C, Fassone E et al (2013) Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability. Am J Hum Genet 92:293–300PubMedPubMedCentral
118.
Zurück zum Zitat Johnson EC, West TW, Ko NU, Strober JB (2011) A 41-year-old man with new headache and altered mental status. Neurohospitalist 1:48–54PubMedPubMedCentral Johnson EC, West TW, Ko NU, Strober JB (2011) A 41-year-old man with new headache and altered mental status. Neurohospitalist 1:48–54PubMedPubMedCentral
119.
Zurück zum Zitat Jia Z, Wang X, Qin Y, Xue L, Jiang P, Meng Y, Shi S, Wang Y, Qin Mo J, Guan MX (2013) Coronary heart disease is associated with a mutation in mitochondrial tRNA. Hum Mol Genet 22:4064–4073PubMedPubMedCentral Jia Z, Wang X, Qin Y, Xue L, Jiang P, Meng Y, Shi S, Wang Y, Qin Mo J, Guan MX (2013) Coronary heart disease is associated with a mutation in mitochondrial tRNA. Hum Mol Genet 22:4064–4073PubMedPubMedCentral
120.
Zurück zum Zitat Choi J-H, Yoon H-R, Kim G-H, Park S-J, Shin Y-L, Yoo H-W (2007) Identification of novel mutations of the HADHA and HADHB genes in patients with mitochondrial trifunctional protein deficiency. Int J Mol Med 19:81–87PubMed Choi J-H, Yoon H-R, Kim G-H, Park S-J, Shin Y-L, Yoo H-W (2007) Identification of novel mutations of the HADHA and HADHB genes in patients with mitochondrial trifunctional protein deficiency. Int J Mol Med 19:81–87PubMed
121.
Zurück zum Zitat Yajima N, Yazaki Y, Yoshida K, Sano K, Takahashi W, Sasaki Y, Ikeda U (2009) A case of mitochondrial cardiomyopathy with pericardial effusion evaluated by 99m Tc-MIBI myocardial scintigraphy. J Nucl Cardiol 16:989–994PubMed Yajima N, Yazaki Y, Yoshida K, Sano K, Takahashi W, Sasaki Y, Ikeda U (2009) A case of mitochondrial cardiomyopathy with pericardial effusion evaluated by 99m Tc-MIBI myocardial scintigraphy. J Nucl Cardiol 16:989–994PubMed
122.
Zurück zum Zitat Mackenzie RM, Salt IP, Miller WH, Logan A, Ibrahim HA, Degasperi A et al (2012) Mitochondrial reactive oxygen species enhance AMP-activated protein kinase activation in the endothelium of patients with coronary artery disease and diabetes. Clin Sci 124:403–411PubMedCentral Mackenzie RM, Salt IP, Miller WH, Logan A, Ibrahim HA, Degasperi A et al (2012) Mitochondrial reactive oxygen species enhance AMP-activated protein kinase activation in the endothelium of patients with coronary artery disease and diabetes. Clin Sci 124:403–411PubMedCentral
123.
Zurück zum Zitat Ferres-Sanchez P, Subirana-Domenech M, Torner-Soler M (1995) Chest pain during exercise as first manifestation of Friedreich’s ataxia. Heart. 74:464–467 Ferres-Sanchez P, Subirana-Domenech M, Torner-Soler M (1995) Chest pain during exercise as first manifestation of Friedreich’s ataxia. Heart. 74:464–467
124.
Zurück zum Zitat Sobenin IA, Sazonova MA, Ivanova MM, Zhelankin AV, Myasoedova VA, Postnov AY et al (2012) Mutation C3256T of mitochondrial genome in white blood cells: novel genetic marker of atherosclerosis and coronary heart disease. PLoS One 7:e46573PubMedPubMedCentral Sobenin IA, Sazonova MA, Ivanova MM, Zhelankin AV, Myasoedova VA, Postnov AY et al (2012) Mutation C3256T of mitochondrial genome in white blood cells: novel genetic marker of atherosclerosis and coronary heart disease. PLoS One 7:e46573PubMedPubMedCentral
125.
Zurück zum Zitat Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S (2017) Mitochondrial disease and endocrine dysfunction. Nat Rev Endocrinol 13:92–104PubMed Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S (2017) Mitochondrial disease and endocrine dysfunction. Nat Rev Endocrinol 13:92–104PubMed
126.
Zurück zum Zitat Schaefer AM, Walker M, Turnbull DM, Taylor RW (2013) Endocrine disorders in mitochondrial disease. Mol Cell Endocrinol 379:2–11PubMedPubMedCentral Schaefer AM, Walker M, Turnbull DM, Taylor RW (2013) Endocrine disorders in mitochondrial disease. Mol Cell Endocrinol 379:2–11PubMedPubMedCentral
127.
Zurück zum Zitat Finsterer J, Strobl W (2012) Brachydactylia as a phenotypic feature of mitochondrial disorder. Acta Med Iran 50:831–835 Finsterer J, Strobl W (2012) Brachydactylia as a phenotypic feature of mitochondrial disorder. Acta Med Iran 50:831–835
128.
Zurück zum Zitat Kalogeris T, Bao Y, Korthuis RJ (2014) Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning. Redox Biol 2:702–714PubMedPubMedCentral Kalogeris T, Bao Y, Korthuis RJ (2014) Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning. Redox Biol 2:702–714PubMedPubMedCentral
129.
Zurück zum Zitat Brown DA, Sabbah HN, Shaikh SR (2013) Mitochondrial inner membrane lipids and proteins as targets for decreasing cardiac ischemia/reperfusion injury. Pharmacol Ther 140:258–266PubMed Brown DA, Sabbah HN, Shaikh SR (2013) Mitochondrial inner membrane lipids and proteins as targets for decreasing cardiac ischemia/reperfusion injury. Pharmacol Ther 140:258–266PubMed
130.
Zurück zum Zitat Mirzaei H, Momeni F, Saadatpour L, Sahebkar A, Goodarzi M, Masoudifar A, Kouhpayeh S, Salehi H, Mirzaei HR, Jaafari MR (2018) MicroRNA: relevance to stroke diagnosis, prognosis, and therapy. J Cell Physiol 233:856–865PubMed Mirzaei H, Momeni F, Saadatpour L, Sahebkar A, Goodarzi M, Masoudifar A, Kouhpayeh S, Salehi H, Mirzaei HR, Jaafari MR (2018) MicroRNA: relevance to stroke diagnosis, prognosis, and therapy. J Cell Physiol 233:856–865PubMed
131.
Zurück zum Zitat Ahmed S, Khan H, Mirzaei H (2019) Mechanics insights of curcumin in myocardial ischemia: where are we standing? Eur J Med Chem 183:111658PubMed Ahmed S, Khan H, Mirzaei H (2019) Mechanics insights of curcumin in myocardial ischemia: where are we standing? Eur J Med Chem 183:111658PubMed
132.
Zurück zum Zitat Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H (2018) NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol 233:2116–2132 Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H (2018) NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol 233:2116–2132
133.
Zurück zum Zitat Rashidi B, Hoseini Z, Sahebkar A, Mirzaei H (2017) Anti-atherosclerotic effects of vitamins D and E in suppression of atherogenesis. J Cell Physiol 232:2968–2976PubMed Rashidi B, Hoseini Z, Sahebkar A, Mirzaei H (2017) Anti-atherosclerotic effects of vitamins D and E in suppression of atherogenesis. J Cell Physiol 232:2968–2976PubMed
135.
Zurück zum Zitat Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R (2009) A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 11:414–430PubMedPubMedCentral Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R (2009) A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 11:414–430PubMedPubMedCentral
136.
Zurück zum Zitat DiMauro S, Tanji K, Schon EA (2012) The many clinical faces of cytochrome c oxidase deficiency. Adv Exp Med Biol 341–357 DiMauro S, Tanji K, Schon EA (2012) The many clinical faces of cytochrome c oxidase deficiency. Adv Exp Med Biol 341–357
137.
Zurück zum Zitat Chevallier JA, Koenig MK (2012) Friedreich-like ataxia as an initial manifestation of mitochondrial DNA 8344A>G mutation. J Child Neurol 27:1056–1058PubMed Chevallier JA, Koenig MK (2012) Friedreich-like ataxia as an initial manifestation of mitochondrial DNA 8344A>G mutation. J Child Neurol 27:1056–1058PubMed
139.
Zurück zum Zitat Terman A, Kurz T, Gustafsson B, Brunk UT (2008) The involvement of lysosomes in myocardial aging and disease. Curr Cardiol Rev 4:107–115PubMedPubMedCentral Terman A, Kurz T, Gustafsson B, Brunk UT (2008) The involvement of lysosomes in myocardial aging and disease. Curr Cardiol Rev 4:107–115PubMedPubMedCentral
140.
Zurück zum Zitat Sebastiani M, Giordano C, Nediani C, Travaglini C, Borchi E, Zani M, Feccia M, Mancini M, Petrozza V, Cossarizza A, Gallo P, Taylor RW, d’Amati G (2007) Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies. J Am Coll Cardiol 50:1362–1369PubMed Sebastiani M, Giordano C, Nediani C, Travaglini C, Borchi E, Zani M, Feccia M, Mancini M, Petrozza V, Cossarizza A, Gallo P, Taylor RW, d’Amati G (2007) Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies. J Am Coll Cardiol 50:1362–1369PubMed
141.
Zurück zum Zitat Hansson A, Hance N, Dufour E, Rantanen A, Hultenby K, Clayton DA, Wibom R, Larsson NG (2004) A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci 101:3136–3141PubMed Hansson A, Hance N, Dufour E, Rantanen A, Hultenby K, Clayton DA, Wibom R, Larsson NG (2004) A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci 101:3136–3141PubMed
142.
Zurück zum Zitat Russell LK, Mansfield CM, Lehman JJ, Kovacs A, Courtois M, Saffitz JE et al (2004) Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator-1α promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res 94:525–533PubMed Russell LK, Mansfield CM, Lehman JJ, Kovacs A, Courtois M, Saffitz JE et al (2004) Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator-1α promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res 94:525–533PubMed
143.
Zurück zum Zitat Lehman JJ, Kelly DP (2002) Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail Rev 7:175–185PubMed Lehman JJ, Kelly DP (2002) Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail Rev 7:175–185PubMed
144.
Zurück zum Zitat Li Y, Huang T-T, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11:376–381PubMed Li Y, Huang T-T, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11:376–381PubMed
145.
Zurück zum Zitat Dai DF, Chen T, Wanagat J, Laflamme M, Marcinek DJ, Emond MJ, Ngo CP, Prolla TA, Rabinovitch PS (2010) Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell 9:536–544PubMedPubMedCentral Dai DF, Chen T, Wanagat J, Laflamme M, Marcinek DJ, Emond MJ, Ngo CP, Prolla TA, Rabinovitch PS (2010) Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell 9:536–544PubMedPubMedCentral
146.
Zurück zum Zitat Grings M, Tonin AM, Knebel LA, Zanatta Â, Moura AP, Dutra Filho CS et al (2012) Phytanic acid disturbs mitochondrial homeostasis in heart of young rats: a possible pathomechanism of cardiomyopathy in Refsum disease. Mol Cell Biochem 366:335–343PubMed Grings M, Tonin AM, Knebel LA, Zanatta Â, Moura AP, Dutra Filho CS et al (2012) Phytanic acid disturbs mitochondrial homeostasis in heart of young rats: a possible pathomechanism of cardiomyopathy in Refsum disease. Mol Cell Biochem 366:335–343PubMed
147.
Zurück zum Zitat Spencer CT, Bryant RM, Day J, Gonzalez IL, Colan SD, Thompson WR, Berthy J, Redfearn SP, Byrne BJ (2006) Cardiac and clinical phenotype in Barth syndrome. Pediatrics. 118:e337–ee46PubMed Spencer CT, Bryant RM, Day J, Gonzalez IL, Colan SD, Thompson WR, Berthy J, Redfearn SP, Byrne BJ (2006) Cardiac and clinical phenotype in Barth syndrome. Pediatrics. 118:e337–ee46PubMed
148.
Zurück zum Zitat Paukov V, Protsenko D (1996) The intermitochondrial contacts of cardiomyocytes during cardiac adaptation under pathological conditions. Arkh Patol 58:43–50PubMed Paukov V, Protsenko D (1996) The intermitochondrial contacts of cardiomyocytes during cardiac adaptation under pathological conditions. Arkh Patol 58:43–50PubMed
149.
Zurück zum Zitat Catteruccia M, Verrigni D, Martinelli D, Torraco A, Agovino T, Bonafé L, D'Amico A, Donati MA, Adorisio R, Santorelli FM, Carrozzo R, Bertini E, Dionisi-Vici C (2014) Persistent pulmonary arterial hypertension in the newborn (PPHN): a frequent manifestation of TMEM70 defective patients. Mol Genet Metab 111:353–359PubMed Catteruccia M, Verrigni D, Martinelli D, Torraco A, Agovino T, Bonafé L, D'Amico A, Donati MA, Adorisio R, Santorelli FM, Carrozzo R, Bertini E, Dionisi-Vici C (2014) Persistent pulmonary arterial hypertension in the newborn (PPHN): a frequent manifestation of TMEM70 defective patients. Mol Genet Metab 111:353–359PubMed
150.
Zurück zum Zitat Singh RB, Dandekar SP, Elimban V, Gupta SK, Dhalla NS (2004) Role of proteases in the pathophysiology of cardiac disease. Mol Cell Biochem 263:241–256PubMed Singh RB, Dandekar SP, Elimban V, Gupta SK, Dhalla NS (2004) Role of proteases in the pathophysiology of cardiac disease. Mol Cell Biochem 263:241–256PubMed
151.
Zurück zum Zitat Shao D, Tian R (2011) Glucose transporters in cardiac metabolism and hypertrophy. Compr Physiol 6:331–351 Shao D, Tian R (2011) Glucose transporters in cardiac metabolism and hypertrophy. Compr Physiol 6:331–351
152.
Zurück zum Zitat Bulthuis EP, Adjobo-Hermans MJ, Willems PH, Koopman WJ (2019) Mitochondrial morphofunction in mammalian cells. Antioxid Redox Signal 30:2066–2109PubMedPubMedCentral Bulthuis EP, Adjobo-Hermans MJ, Willems PH, Koopman WJ (2019) Mitochondrial morphofunction in mammalian cells. Antioxid Redox Signal 30:2066–2109PubMedPubMedCentral
153.
Zurück zum Zitat Spiegel R, Khayat M, Shalev SA, Horovitz Y, Mandel H, Hershkovitz E, Barghuti F, Shaag A, Saada A, Korman SH, Elpeleg O, Yatsiv I (2011) TMEM70 mutations are a common cause of nuclear encoded ATP synthase assembly defect: further delineation of a new syndrome. J Med Genet 48:177–182PubMed Spiegel R, Khayat M, Shalev SA, Horovitz Y, Mandel H, Hershkovitz E, Barghuti F, Shaag A, Saada A, Korman SH, Elpeleg O, Yatsiv I (2011) TMEM70 mutations are a common cause of nuclear encoded ATP synthase assembly defect: further delineation of a new syndrome. J Med Genet 48:177–182PubMed
154.
Zurück zum Zitat Vydt TC, de Coo RF, Soliman OI, Folkert J, van Geuns R-JM, Vletter WB et al (2007) Cardiac involvement in adults with m.3243A>G MELAS gene mutation. Am J Cardiol 99:264–269PubMed Vydt TC, de Coo RF, Soliman OI, Folkert J, van Geuns R-JM, Vletter WB et al (2007) Cardiac involvement in adults with m.3243A>G MELAS gene mutation. Am J Cardiol 99:264–269PubMed
155.
Zurück zum Zitat Rahman S (2015) Emerging aspects of treatment in mitochondrial disorders. J Inherit Metab Dis 38:641–653PubMed Rahman S (2015) Emerging aspects of treatment in mitochondrial disorders. J Inherit Metab Dis 38:641–653PubMed
156.
Zurück zum Zitat Bit-Avragim N, Perrot A, Schöls L, Hardt C, Kreuz FR, Zühlke C, Bubel S, Laccone F, Vogel HP, Dietz R, Osterziel KJ (2001) The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia. J Mol Med 78:626–632PubMed Bit-Avragim N, Perrot A, Schöls L, Hardt C, Kreuz FR, Zühlke C, Bubel S, Laccone F, Vogel HP, Dietz R, Osterziel KJ (2001) The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia. J Mol Med 78:626–632PubMed
157.
Zurück zum Zitat Albano LMJ, Nishioka SAD, Moysés RL, Wagenführ J, Bertola D, Sugayama SMM, Chong AK (2002) Friedreich's ataxia: cardiac evaluation of 25 patients with clinical diagnosis and literature review. Arq Bras Cardiol 78:448–451 Albano LMJ, Nishioka SAD, Moysés RL, Wagenführ J, Bertola D, Sugayama SMM, Chong AK (2002) Friedreich's ataxia: cardiac evaluation of 25 patients with clinical diagnosis and literature review. Arq Bras Cardiol 78:448–451
158.
Zurück zum Zitat Koeppen AH, Michael SC, Knutson MD, Haile DJ, Qian J, Levi S, Santambrogio P, Garrick MD, Lamarche JB (2007) The dentate nucleus in Friedreich’s ataxia: the role of iron-responsive proteins. Acta Neuropathol 114:163–173PubMed Koeppen AH, Michael SC, Knutson MD, Haile DJ, Qian J, Levi S, Santambrogio P, Garrick MD, Lamarche JB (2007) The dentate nucleus in Friedreich’s ataxia: the role of iron-responsive proteins. Acta Neuropathol 114:163–173PubMed
159.
Zurück zum Zitat Regner SR, Lagedrost SJ, Plappert T, Paulsen EK, Friedman LS, Snyder ML, Perlman SL, Mathews KD, Wilmot GR, Schadt KA, Sutton MSJ, Lynch DR (2012) Analysis of echocardiograms in a large heterogeneous cohort of patients with Friedreich ataxia. Am J Cardiol 109:401–405PubMed Regner SR, Lagedrost SJ, Plappert T, Paulsen EK, Friedman LS, Snyder ML, Perlman SL, Mathews KD, Wilmot GR, Schadt KA, Sutton MSJ, Lynch DR (2012) Analysis of echocardiograms in a large heterogeneous cohort of patients with Friedreich ataxia. Am J Cardiol 109:401–405PubMed
160.
Zurück zum Zitat Meyer C, Schmid G, Görlitz S, Ernst M, Wilkens C, Wilhelms I et al (2007) Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI. Mov Disord 22:1615–1622PubMed Meyer C, Schmid G, Görlitz S, Ernst M, Wilkens C, Wilhelms I et al (2007) Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI. Mov Disord 22:1615–1622PubMed
161.
Zurück zum Zitat Sproule DM, Kaufmann P (2008) Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 1142:133–158PubMed Sproule DM, Kaufmann P (2008) Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 1142:133–158PubMed
162.
Zurück zum Zitat Al-Enezi M, Al-Saleh H, Nasser M (2008) Mitochondrial disorders with significant ophthalmic manifestations. Middle East Afr J Ophthalmol 15:81–86PubMed Al-Enezi M, Al-Saleh H, Nasser M (2008) Mitochondrial disorders with significant ophthalmic manifestations. Middle East Afr J Ophthalmol 15:81–86PubMed
163.
Zurück zum Zitat O’Toole JF (2014) Renal manifestations of genetic mitochondrial disease. Int J Nephrol Renov Dis 7:57 O’Toole JF (2014) Renal manifestations of genetic mitochondrial disease. Int J Nephrol Renov Dis 7:57
165.
Zurück zum Zitat Lorenzoni PJ, Werneck LC, Kay CSK, Silvado CES, Scola RH (2015) When should MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) be the diagnosis? Arq Neuropsiquiatr 73:959–967PubMed Lorenzoni PJ, Werneck LC, Kay CSK, Silvado CES, Scola RH (2015) When should MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) be the diagnosis? Arq Neuropsiquiatr 73:959–967PubMed
166.
Zurück zum Zitat Diegoli M, Grasso M, Favalli V, Serio A, Gambarin FI, Klersy C, Pasotti M, Agozzino E, Scelsi L, Ferlini A, Febo O, Piccolo G, Tavazzi L, Narula J, Arbustini E (2011) Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. J Am Coll Cardiol 58:925–934PubMed Diegoli M, Grasso M, Favalli V, Serio A, Gambarin FI, Klersy C, Pasotti M, Agozzino E, Scelsi L, Ferlini A, Febo O, Piccolo G, Tavazzi L, Narula J, Arbustini E (2011) Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. J Am Coll Cardiol 58:925–934PubMed
167.
Zurück zum Zitat White KL, Chen JM, Margot NA, Wrin T, Petropoulos CJ, Naeger LK, Swaminathan S, Miller MD (2004) Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations. Antimicrob Agents Chemother 48:992–1003PubMedPubMedCentral White KL, Chen JM, Margot NA, Wrin T, Petropoulos CJ, Naeger LK, Swaminathan S, Miller MD (2004) Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations. Antimicrob Agents Chemother 48:992–1003PubMedPubMedCentral
168.
Zurück zum Zitat Clarke SL, Bowron A, Gonzalez IL, Groves SJ, Newbury-Ecob R, Clayton N et al (2013) Barth syndrome. Orphanet J Rare Dis 8:23PubMedPubMedCentral Clarke SL, Bowron A, Gonzalez IL, Groves SJ, Newbury-Ecob R, Clayton N et al (2013) Barth syndrome. Orphanet J Rare Dis 8:23PubMedPubMedCentral
169.
Zurück zum Zitat Laurent D, Edwards JG (2014) Alcoholic cardiomyopathy: multigenic changes underlie cardiovascular dysfunction. J Cardiol Clin Res 2:1 Laurent D, Edwards JG (2014) Alcoholic cardiomyopathy: multigenic changes underlie cardiovascular dysfunction. J Cardiol Clin Res 2:1
170.
Zurück zum Zitat Finsterer J, Llberger CS (2009) Neuromuscular disorders associated with apical hypertrophic cardiomyopathy. Acta Cardiol 64:85–89PubMed Finsterer J, Llberger CS (2009) Neuromuscular disorders associated with apical hypertrophic cardiomyopathy. Acta Cardiol 64:85–89PubMed
171.
Zurück zum Zitat Buda P, Wieteska-Klimczak A, Ksiazyk J, Smorczewska-Kiljan A, Gietka P, Czartoryska B, Tylki-Szymańska A (2011) Diagnostic problems in a 17-year-old patient with gastrointestinal manifestations of Fabry disease. Med Wieku Rozwoj 15:69–72PubMed Buda P, Wieteska-Klimczak A, Ksiazyk J, Smorczewska-Kiljan A, Gietka P, Czartoryska B, Tylki-Szymańska A (2011) Diagnostic problems in a 17-year-old patient with gastrointestinal manifestations of Fabry disease. Med Wieku Rozwoj 15:69–72PubMed
172.
Zurück zum Zitat Baik R, Chae JH, Lee YM, Kang HC, Lee JS, Kim HD (2010) Electrocardiography as an early cardiac screening test in children with mitochondrial disease. Korean J Pediatr 53:644–647PubMedPubMedCentral Baik R, Chae JH, Lee YM, Kang HC, Lee JS, Kim HD (2010) Electrocardiography as an early cardiac screening test in children with mitochondrial disease. Korean J Pediatr 53:644–647PubMedPubMedCentral
173.
Zurück zum Zitat Berkman N, Henderson J, Fiordalisi C, Hartling L, Newberry S, Guise J et al (1993–2019) In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds) GeneReviews®[Internet]. University of Washington, Seattle, Seattle. Available from http://www.ncbi.nlm.nih.gov/books/NBK1116/PubMed Mol Imaging Biol. 2012;14:4–13 Berkman N, Henderson J, Fiordalisi C, Hartling L, Newberry S, Guise J et al (1993–2019) In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds) GeneReviews®[Internet]. University of Washington, Seattle, Seattle. Available from http://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK1116/​PubMed Mol Imaging Biol. 2012;14:4–13
174.
Zurück zum Zitat Gobu P, Karthikeyan B, Prasath A, Santhosh S, Balachander J (2010) Kearns Sayre syndrome (KSS)-a rare cause for cardiac pacing. Indian Pacing Electrophysiol J 10:547 Gobu P, Karthikeyan B, Prasath A, Santhosh S, Balachander J (2010) Kearns Sayre syndrome (KSS)-a rare cause for cardiac pacing. Indian Pacing Electrophysiol J 10:547
175.
Zurück zum Zitat Puri A, Pradhan A, Chaudhary G, Singh V, Sethi R, Narain VS (2012) Symptomatic complete heart block leading to a diagnosis of Kearns–Sayre syndrome. Indian Heart J 64:515–517PubMedPubMedCentral Puri A, Pradhan A, Chaudhary G, Singh V, Sethi R, Narain VS (2012) Symptomatic complete heart block leading to a diagnosis of Kearns–Sayre syndrome. Indian Heart J 64:515–517PubMedPubMedCentral
176.
Zurück zum Zitat Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NM et al (2013) 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 61:e6–e75PubMed Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NM et al (2013) 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol 61:e6–e75PubMed
177.
Zurück zum Zitat Vardas PE, Auricchio A, Blanc J-J, Daubert J-C, Drexler H, Ector H et al (2007) Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 28:2256–2295PubMed Vardas PE, Auricchio A, Blanc J-J, Daubert J-C, Drexler H, Ector H et al (2007) Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 28:2256–2295PubMed
178.
Zurück zum Zitat Panas M, Gialafos E, Spengos K, Papaioannou TG, Aggeli K, Kladi A et al (2010) Prevalence of interatrial block in patients with Friedreich’s ataxia. Int J Cardiol 145:386–387PubMed Panas M, Gialafos E, Spengos K, Papaioannou TG, Aggeli K, Kladi A et al (2010) Prevalence of interatrial block in patients with Friedreich’s ataxia. Int J Cardiol 145:386–387PubMed
179.
Zurück zum Zitat Fayssoil A (2009) Heart diseases in mitochondrial encephalomyopathy, lactic acidosis, and stroke syndrome. Congest Heart Fail 15:284–287PubMed Fayssoil A (2009) Heart diseases in mitochondrial encephalomyopathy, lactic acidosis, and stroke syndrome. Congest Heart Fail 15:284–287PubMed
180.
Zurück zum Zitat Dedkova EN, Blatter LA (2012) Measuring mitochondrial function in intact cardiac myocytes. J Mol Cell Cardiol 52:48–61PubMed Dedkova EN, Blatter LA (2012) Measuring mitochondrial function in intact cardiac myocytes. J Mol Cell Cardiol 52:48–61PubMed
Metadaten
Titel
Cardiac complications in inherited mitochondrial diseases
verfasst von
Mohaddeseh Behjati
Mohammad Reza Sabri
Masood Etemadi Far
Majid Nejati
Publikationsdatum
29.07.2020
Verlag
Springer US
Schlagwort
Cardiomyopathy
Erschienen in
Heart Failure Reviews / Ausgabe 2/2021
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-020-10009-1

Weitere Artikel der Ausgabe 2/2021

Heart Failure Reviews 2/2021 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.